Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh, Jian Chai, Ting Tang, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1118-1118
Open Access | Times Cited: 988
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 253
Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits
Javad Sharifi‐Rad, Cristina Quispe, Muhammad Imran, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 238
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Nand Kishor Roy, Parama Dey, Kishore Banik, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4101-4101
Open Access | Times Cited: 184
Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy
Jiatong Liu, Xiaoyue Han, Tingyue Zhang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 180
Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
Sankhadip Bose, Sabyasachi Banerjee, Arijit Mondal, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1451-1451
Open Access | Times Cited: 161
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
Sushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Science Advances (2022) Vol. 8, Iss. 7
Open Access | Times Cited: 159
Focus on Formononetin: Anticancer Potential and Molecular Targets
Samantha Ong, Muthu K. Shanmugam, Lu Fan, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 611-611
Open Access | Times Cited: 158
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 136
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Qian Hu, Qihui Bian, Dingchao Rong, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 133
Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Abdul Basit Baba, Bilal Rah, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 124
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 110
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
Nazeer Hasan, Arif Nadaf, Mohammad Imran, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 101
STAT3 pathway in cancers: Past, present, and future
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 100
JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
Fettah Erdogan, Tudor B. Radu, Anna Orlova, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 7, pp. 2049-2062
Open Access | Times Cited: 74
JAK: Not Just Another Kinase
Ruchi Agashe, Scott M. Lippman, Razelle Kurzrock
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 12, pp. 1757-1764
Open Access | Times Cited: 70
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 50
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 32
Curcumin, its derivatives, and their nanoformulations: Revolutionizing cancer treatment
Iftikhar Ahmad, Sameer Ahmad, Ausaf Ahmad, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 18
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
JAK/STAT signaling in hepatocellular carcinoma
Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
Hepatic Oncology (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 125
Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Habbanakuppe D. Preetham, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 157-182
Closed Access | Times Cited: 122
Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
Jong Hyun Lee, Chakrabhavi Dhananjaya Mohan, Amudha Deivasigamani, et al.
Journal of Advanced Research (2020) Vol. 26, pp. 83-94
Open Access | Times Cited: 121
Page 1 - Next Page

Scroll to top